Graff, T., Chawla, S. B., Jun, M., Heaps, N., Alshreef, A., Tybor, D., Zawadzki, N., Spurrier, K., Shafrin, J. (2025). Operational efficiencies and cost savings of using one bispecific antibody FDA-approved for both R/R 3L+ DLBCL and FL. Blood. https://doi.org/10.1182/blood-2025-7942